Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Mallinckrodt
Accenture
Cipla
McKinsey
Fish and Richardson
Argus Health
Queensland Health
Boehringer Ingelheim

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074911

« Back to Dashboard

NDA 074911 describes PHRENILIN WITH CAFFEINE AND CODEINE, which is a drug marketed by Valeant and is included in one NDA. Additional details are available on the PHRENILIN WITH CAFFEINE AND CODEINE profile page.

The generic ingredient in PHRENILIN WITH CAFFEINE AND CODEINE is acetaminophen; butalbital; caffeine; codeine phosphate. There are sixty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine; codeine phosphate profile page.
Summary for 074911
Tradename:PHRENILIN WITH CAFFEINE AND CODEINE
Applicant:Valeant
Ingredient:acetaminophen; butalbital; caffeine; codeine phosphate
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength325MG;50MG;40MG;30MG
Approval Date:Aug 22, 2001TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Fish and Richardson
Healthtrust
Daiichi Sankyo
US Army
Chubb
Harvard Business School
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.